The prognostic significance of IDH mutations in Acute Myeloid Leukemia remains a subject of ongoing debate, influenced by the clinical context, co-occurring genetic alterations, and specific mutational hotspots [24]. This evidence concerns the gene IDH2 and acute myeloid leukemia.